70 Biggest Movers From Yesterday

Gainers

• Arvinas, Inc. ARVN shares climbed 95.1% to close at $58.38 on Monday after the company reported interim clinical data for its cancer treatment. The company said ARV-471 showed evidence of anti-tumor activity.
• BioCardia, Inc. BCDA shares climbed 58.9% to close at $4.48. BioCardia said it expects data safety monitoring board verbal feedback for interim data from Phase 3 CardiaAMP heart failure trial by the end of December 15, 2020.
• Veru Inc. VERU shares gained 52.6% to close at $9.69. Veru reported Phase 2 trial results for enobosarm for endocrine resistant metastatic breast cancer.
• Rubius Therapeutics, Inc. RUBY jumped 36.6% to close at $8.73 after declining around 17% on Friday.
• AnPac Bio-Medical Science Co., Ltd. ANPC rose 35.1% to close at $5.70 after the company said it made significant progress in detecting pre-cancer diseases.
• GasLog Partners LP GLOP surged 31.2% to close at $3.45.
• Big Rock Partners Acquisition Corp. BRPA gained 29.4% to close at $15.20.
• Alexion Pharmaceuticals, Inc. ALXN shares surged 29.2% to close at $156.31 after AstraZeneca plc AZN announced plans buy the company for $39 billion.
• CooTek (Cayman) Inc. CTK rose 28.4% to close at $6.33. CooTek released quarterly earnings today.
• Teligent, Inc. TLGT gained 28.2% to close at $0.8085 after declining over 8% on Friday. A Special Meeting of Stockholders is scheduled to reconvene on Wednesday December 16.
• BioLineRx Ltd. BLRX rose 27% to close at $3.39.
• Humanigen, Inc. HGEN gained 26.3% to close at $11.96.
• ReneSola Ltd SOL shares jumped 26% to close at $6.98. HC Wainwright & Co. maintained ReneSola with a Buy and raised the price target from $4 to $12.
• Mid-Con Energy Partners, LP MCEP surged 25.6% to close at $3.78.
• Evelo Biosciences, Inc. EVLO gained 24.8% to close at $9.41 after jumping around 18% on Friday. Evelo Biosciences, last week, reported new clinical candidate in oncology.
• Arbutus Biopharma Corporation ABUS surged 24.8% to close at $4.88. Arbutus Biopharma, last week, announced additional clinical data from an ongoing Phase 1a/1b clinical trial with AB-729.
• Chinook Therapeutics, Inc. KDNY climbed 23.1% to close at $16.40. Chinook Therapeutics reported a license agreement with Morehouse School of Medicine for development of therapies in kidney diseases disproportionately affecting African Americans and underserved communities.
• Graybug Vision, Inc. GRAY gained 22.6% to close at $22.81.
• Nurix Therapeutics, Inc. NRIX shares climbed 22% to close at $48.44.
• DermTech, Inc. DMTK shares climbed 21.4% to close at $13.95. DermTech, on Friday, announced Inclusion of its melanoma test in two continuing medical education sessions at 2020 Fall Clinical Virtual Grand Rounds and Mount Sinai Winter Symposium.
• Domo, Inc. DOMO gained 20.8% to close at $56.43
• Summit Wireless Technologies, Inc. WISA jumped 20.3% to close at $3.14 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced a $3.5 price target.
• Tarsus Pharmaceuticals, Inc. TARS gained 20.1% to close at $41.53.
• O2Micro International Limited OIIM shares rose 18.1% to close at $7.57.
• Centrus Energy Corp. LEU gained 17.9% to close at $20.98.
• Catalyst Biosciences, Inc. CBIO surged 17.6% to close at $7.29. Catalyst Biosciences, last week, presented Crimson 1 Phase 3 study design at the 62nd Annual American Society of Hematology Conference.
• Calix, Inc. CALX gained 17.2% to close at $29.06. Arlo, last week, announced a strategic partnership with Calix.
• Homology Medicines, Inc. FIXX jumped 17% to close at $11.97.
• Prelude Therapeutics Incorporated PRLD gained 17% to close at $72.67.
• Marathon Patent Group, Inc. MARA shares rose 16.6% to close at $5.54 after declining 9% on Friday. HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $7.5 to $9. Marathon Patent Group last week purchased additional 10K S-19j Pro ASIC miners from Bitmain and announced plans to open a second data center.
• Sterling Construction Company, Inc. STRL gained 16.5% to close at $19.30.
• Vince Holding Corp. VNCE shares rose 16.3% to close at $6.98 after the company reported completion of third lien credit facility. Vince said it projects preliminary Q3 sales of $69 million.
• Gatos Silver, Inc. GATO shares climbed 16.1% to close at $8.73. Gatos Silver reported quarterly results last week.
• Recro Pharma, Inc. REPH rose 16.1% to close at $3.43 after climbing around 37% on Friday.
• BioVie Inc. BIVI gained 15.9% to close at $12.00.
• Social Capital Hedosophia Holdings Corp. II IPOB gained 15.9% to close at $29.48.
• Syros Pharmaceuticals, Inc. SYRS shares gained 14.8% to close at $11.65.
• Prothena Corporation plc PRTA surged 14% to close at $12.73.
• Synlogic Inc SYBX shares rose 13.4% to close at $2.54 after the company announced plans to advance its cancer treatment into the combination therapy stage of its phase 1 trial.
• Atomera Incorporated ATOM gained 10.9% to close at $12.00.
• C4 Therapeutics, Inc. CCCC rose 10.8% to close at $32.15.
• Inseego Corp. INSG gained 10.2% to close at $15.16 after climbing 12% on Friday. The company on Thursday announced its 5G MiFi M2000 mobile hotspot is now available at T-Mobile and on Friday announced the availability of 5G MiFi M200 in Japan.
• Apellis Pharmaceuticals, Inc. APLS gained 8.8% to close at $52.05. Apellis and Sobi last week reported top-lone results at 48 weeks from Phase 3 PEGASUS study of pegcetacoplan in PNH.
• Aligos Therapeutics, Inc. ALGS rose 7.6% to close at $23.80.
• 22nd Century Group, Inc. XXII fell 7.5% to close at $2.35 after climbing 18% on Friday.
• Socket Mobile, Inc. SCKT gained 7.5% to close at $2.86 after the company announced it received a notice of forgiveness from Western Alliance Bank for the $1.06 million PPP loan.
• Prevail Therapeutics Inc. PRVL gained 7% to close at $12.50. Prevail Therapeutics, last week, said first patient was dosed in Phase 1/2 PROCLAIM trial evaluating PR006 for the treatment of frontotemporal dementia patients with GRN mutations.
• Pluralsight, Inc. PS rose 6.4% to close at $20.19 after the company agreed to be acquired by private-equity firm Vista Equity Partners in an all-cash transaction for $20.26 per share..
• GoHealth, Inc. GOCO rose 6% to close at $14.09.

Check out these big penny stock gainers and losers

Losers

• Aerpio Pharmaceuticals, Inc. ARPO shares tumbled 46.7% to close at $1.20 on Monday after the company disclosed results from its phase 2 trial of Razuprotafib glaucoma. HC Wainwright & Co. maintained Aerpio Pharmaceuticals with a Neutral and lowered the price target from $2 to $1.5.
• Fossil Group, Inc. FOSL fell 27.4% to close at $9.65.
• SELLAS Life Sciences Group, Inc. SLS dropped 20.1% to close at $6.69. SELLAS Life Sciences Group shares tumbled around 53% on Friday after the company reported follow-up data from a randomized Phase 2 VADIS trial of Nelipepimut-S in woman with ductal carcinoma in-situ of the breast.
• Titan International, Inc. TWI fell 19.7% to close at $4.21.
• AMC Entertainment Holdings, Inc. AMC dipped 18.6% to close at $3.19.
• Virgin Galactic Holdings, Inc. SPCE shares dipped 17.4% to close at $26.46. A test flight of the VSS Unity from Virgin Galactic returned home early after an ignition failure on Saturday.
• SolarWinds Corporation SWI declined 16.7% to close at $19.62 after the company said some of its products may have been affected by a highly sophisticated hack.
• Eargo, Inc. EAR dipped 16.7% to close at $47.47.
• Greenwich LifeSciences, Inc. GLSI fell 16.4% to close at $46.80 after declining over 22% on Friday. Greenwich LifeSciences last week shared the poster for the GP2 Phase 2b clinical trial final efficacy analysis that was presented Wednesday at the 2020 San Antonio Breast Cancer Symposium.
• TechTarget, Inc. TTGT dropped 16.4% to close at $50.31 after the company reported a proposed offering of convertible senior notes.
• IEC Electronics Corp. IEC fell 15.5% to close at $10.50.
• NextDecade Corporation NEXT dipped 15.1% to close at $2.93 after climbing 38% on Friday.
• AbCellera Biologics Inc. ABCL fell 15.1% to close at $50.01.
• Immutep Limited IMMP fell 14.3% to close at $2.99 after declining over 38% on Friday. Immutep last week reported a statistically significant survival benefit for key patient groups in its ongoing Phase IIb AIPAC study in metastatic breast cancer.
• Destination XL Group, Inc. DXLG declined 14.1% to close at $0.2702 after the company announced it would delist from the Nasdaq.
• Vivos Therapeutics, Inc. VVOS shares declined 13.4% to close at $7.79. Vivos Therapeutics shares climbed around 50% on Friday after the company priced its IPO at $6 per share..
• Xenetic Biosciences, Inc. XBIO declined 11.8% to close at $2.01. Xenetic Biosciences, last week, announced a roughly 2.45 million shares registered direct offering priced at $2.45 per share.
• Team, Inc. TISI fell 10.4% to close at $9.96.
• Fusion Fuel Green PLC HTOO fell 9.9% to close at $17.75.
• Gamida Cell Ltd GMDA shares fell 8.4% to close at $9.09 after the company pushed back its timeline to submit a biologics license application from 2020 to 2H 2021 due to additional data requests from the Food and Drug Administration.
• AstraZeneca PLC AZN fell 7.8% to close at $50.03 after the company announced it would acquire Alexion Pharmaceuticals for $39 billion in cash and stock.